CLEC12A and myelodysplastic syndrome: Recently, overexpression of CLL1 by CD34+ CD38- bone marrow fraction and its various subcompartments (HSC, MPP and LMPP) has been demonstrated in patients with MDS-EB (myelodysplastic syndromes with excess blasts), compared to LR-MDS and healthy individuals (27).